טוען...
Postmenopausal Hormone Therapy and Cardiovascular Disease in Perspective
The totality of data indicate that the window of opportunity for reducing mortality and coronary heart disease (CHD) is initiation of hormone therapy (HT) within 6 years of menopause and/or by 60 years of age and continued for 6 years or more. Additionally, the risks of HT are rare (<1/1,000) esp...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2764865/ https://ncbi.nlm.nih.gov/pubmed/18677151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GRF.0b013e318181de86 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|